2026 Lupus Research Alliance Gala Raises Millions to Advance Lupus Research Breakthroughs
NEW YORK, Nov. 17, 2026
Press Release Disclaimer: This is a press release distributed through the XPR Media network. It has not been independently verified by our newsroom.

![]()
2026 Lupus Research Alliance Gala Raises Millions to Advance Lupus Research Breakthroughs
PR Newswire
NEW YORK, Nov. 17, 2026
Goo Goo Dolls frontman and lead singer, rock and roll icon John Rzeznik headlined the evening, which honored Johnson & Johnson and lupus Hope in Action honoree Anna Fisch
NEW YORK, Nov. 17, 2026 /PRNewswire/ — The Lupus Research Alliance (LRA), the world’s largest private funder of lupus research, hosted its annual Breaking Through Gala last night at the Ziegfeld Ballroom, raising more than $4 million to support critical research aimed at freeing the world of lupus.
Celebrating Hope in Action, the Gala highlighted the remarkable progress in lupus made possible by donors, researchers, clinicians, partners, and people living with lupus. Reflecting that spirit, the event was hosted by Maxwell, the iHeartMedia, Inc. Afternoon Host on 103-5 KTU, “The Beat of New York.” Frontman and principal songwriter of the Goo Goo Dolls, rock and roll icon John Rzeznik gave a stunning performance for attendees.
“I am proud to share my music in support of the Lupus Research Alliance and its work to inspire hope for a cure,” said Mr. Rzeznik. “Music has the power to bring people joy, and I am grateful for the opportunity to support research that drives progress toward better treatments and a future free from lupus.”
The evening celebrated the strong community that is making a meaningful difference in the lives of those living with lupus. Supporters recognized:
- Renowned singers Lady Gaga and Selena Gomez as well as philanthropist Michael R. Bloomberg as Gala Honorary Co-Chairs.
- Event co-chairs included: Lupus Research Alliance Board chair Ira Akselrad; Leonard Dragone, MD, Vice President, Rheumatology and Autoantibody Disease Area Stronghold Leader, Johnson & Johnson Innovative Medicine R&D; New York Jets Chairman The Honorable Robert Wood Johnson; Faith Majors, actress, speaker, and writer living with lupus; philanthropist Terri Friedman; and Veronica Vargas Lupo, Lupus Research Alliance Board of Directors member and author.
- Lupus Research Alliance Young Leader Co-Chairs Madeline Bustamante and Liuna Fekravar.
Honorees were recognized for their extraordinary contributions to the Lupus Research Alliance and lupus community:
- Johnson & Johnson as Industry Partner Honoree. Johnson & Johnson has been a valued partner of the Lupus Research Alliance since its inception. Since 2010, the company has donated millions to fuel groundbreaking research and bring the community together. In accepting the award, Vanessa Broadhurst, Executive Vice President of Global Corporate Affairs at Johnson & Johnson, shared exciting developments in the company’s immunology portfolio, including a potential treatment for lupus.
- Anna Fisch as Hope in Action Honoree. Ms. Fisch’s involvement with the Lupus Research Alliance started more than 30 years ago, shortly after being diagnosed with lupus. Through her work with the organization, she has effectively advocated for federal lupus research funding and currently serves as a voice for patients with government officials, industry partners, and lupus venture investors.
“For more than three decades, the Lupus Research Alliance has been an important part of my journey with lupus, connecting me with a community committed to creating change,” Ms. Fisch said. “It has been a privilege to advocate alongside so many dedicated individuals working toward a future where no one has to live with this disease.”
“Our Gala is fittingly themed Hope in Action because that is exactly what we are seeing across the lupus research landscape today,” said Albert T. Roy, President and CEO of the Lupus Research Alliance. “Thanks to the commitment of our donors and partners, researchers are translating scientific discoveries into real momentum toward better treatments, improved outcomes, and ultimately a cure for people living with lupus.”
A beacon of hope, the Empire State Building illuminated the New York City skyline in red and purple, raising awareness of lupus and the Lupus Research Alliance’s relentless pursuit of a cure through research.
About Lupus
Lupus is a chronic, complex autoimmune disease that affects millions of people worldwide. In lupus, the immune system, meant to defend against infections, produces autoantibodies that mistake the body’s own cells as foreign, causing other immune cells to attack organs such as the kidneys, brain, heart, lungs, and skin, as well as blood and joints. Ninety percent of people with lupus are women, most often diagnosed between the ages of 15-45. Black, Latinx, Indigenous, Asian and Pacific Islander people are disproportionately affected by lupus.
About the Lupus Research Alliance
The Lupus Research Alliance is the largest non-governmental, non-profit funder of lupus research worldwide. The organization aims to transform treatment by funding the most innovative lupus research, fostering scientific talent, and driving discovery toward better diagnostics, improved treatments and, ultimately, a cure for lupus. Because the Lupus Research Alliance’s Board of Directors funds all administrative and fundraising costs, 100% of all donations go to support lupus research programs.
For more information or to donate to lupus research, visit the LRA at LupusResearch.org and on social media at: X, Facebook, LinkedIn, and Instagram.
View original content to download multimedia:https://www.prnewswire.com/news-releases/2026-lupus-research-alliance-gala-raises-millions-to-advance-lupus-research-breakthroughs-302942118.html
SOURCE Lupus Research Alliance
